Delaware Marijuana Activists Stage Boycott Of Medical Dispensaries That Testified Against Legalization Bill – Marijuana Moment
Delaware marijuana activists are mounting a boycott against four medical cannabis operators in the state after representatives of those companies testified in opposition to an adult-use legalization bill last month.
While the Health and Human Development Committee advanced the legislation, advocates say they were “stunned” to hear opposing voices from four of the state’s six medical marijuana companies. Those are: Columbia Care, Fresh Delaware, CannTech and EZY Venture.
The businesses argued that enacting recreational legalization as delineated in the bill would oversaturate the market with retailers and create an oversupply of marijuana. Some explicitly talked about how the reform would hurt their bottom line, while others asserted that the costs of cannabis would become prohibitive for patients.
But advocates aren’t buying it. The Delaware Cannabis Policy Coalition said in a press release on Thursday that the companies opposing HB 150 are “simply obstructing the progress of adult-use legislation” and, in response, “some patients are now staging a boycott of the regulated dispensaries.”
“This market belongs to the long-time consumers, patients, and activists,” Zoë Patchell, executive director of Delaware CAN, said. “We create the demand, we’ve been the ones driving the reform efforts, and we pay the prices at dispensaries. Cannabis